[Cancers of the breast at metastatic high-risk: prediction of survival by steroidal receptors].

@article{Mauriac1989CancersOT,
  title={[Cancers of the breast at metastatic high-risk: prediction of survival by steroidal receptors].},
  author={Louis Mauriac and Michel Durand and Jean Chauvergne and Massimo David and Jean Wafflart},
  journal={Bulletin du cancer},
  year={1989},
  volume={76 1},
  pages={33-41}
}
From 1982 to 1985, 279 patients with locally advanced breast cancer have been treated with induction chemotherapy, adjusted loco-regional treatment (surgery and/or radiotherapy) and adjuvant chemotherapy with or without immunostimulation. Overall and relapse free survivals are better for tumors with estrogen and progesterone receptors (EPR). For these patients, we may hope that tumoral reduction with hormonotherapy would get the same overall and relapse-free survivals as induction chemotherapy.